Surgical Exploitation of Venous Interconnections in Upper Limb for Creation of Arteriovenous Vascular Access for Hemodialysis

Research Article

Austin J Surg. 2016; 3(2): 1087.

Surgical Exploitation of Venous Interconnections in Upper Limb for Creation of Arteriovenous Vascular Access for Hemodialysis

Elamaran E¹* and Hemachandar R²

¹Department of Cardiothoracic and Vascular Surgery, Sri Balaji Vidayapeeth University, India

²Department of Nephrology, Sri Balaji Vidayapeeth University, India

*Corresponding author: Elamaran E, Department of Cardiothoracic and Vascular Surgery, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidayapeeth University, Pondicherry, India

Received: July 19, 2016; Accepted: August 31, 2016; Published: September 06, 2016

Abstract

Aim: This article describes our experience of Arterio Venous (AV) vascular access creation for hemodialysis (HD) and its outcomes.

Results: A total of 107 AV vascular accesses were created in 102 patients from September 2014 to December 2015. Mean follow-up duration was 12 months. The preferred hand was left in 73 (68.22%) patients compared to the right hand 34 (31.77%). Cephalic vein was used in 63 (58.88%) patients, median basilic or antecubital vein in 30 (28.04%) cases, median vein of forearm in 3 (2.80%) cases, saphenous vein in 3 (2.80%), accessory cephalic vein 2 (1.87%) and AV graft in 6 (5.61%) patients. End (vein) to side (artery) anastamosis was done in 39 (36.45%) cases and side to side anastamosis was done in 68 (63.55%) cases. Complications include distal edema in 8 (7.48%) patients, seroma in 2 (1.87%), hematoma in 2 (1.87%), surgical site infection in 2(1.87%), aneurysm in 4 (3.74%) and skin necrosis in 1 (0.93%) patient. Primary failure occurred in 9 (8.41%) patients due to thrombosis and non maturation and secondary failure due to thrombosis in 6 (5.61%) patients.

Conclusion: Venous interconnections of the upper limb provides vascular surgeon an opportunity for successful construction of native Arteriovenous Fistula (AVF) when conventional sites were exhausted.

Keywords: Vascular access; Venous interconnections; Arteriovenous fistula

Introduction

Vascular access is considered as the Achilles heel of hemodialysis. Though AVF is the most ideal vascular option available, AVF could not be created in many patients due to poor quality of blood vessels from prior venipuncture, cannulation, poor calibre of vessels and arteriosclerosis. Though AVG has its own advantages, it is more costly and has more complications than AVF. Hence we exploited the variations of venous anatomy in upper limb to create AVF in all patients. In this context, we analysed AVF creation procedures, its complications and outcomes.

Materials and Methods

This prospective observational single centre study was carried out in our institute from September 2014 to December 2015. Patients were assessed for their feasibilities of AVF creation by physical examination of superficial venous system and Allen test which assesses the arterial competence of palmar arch. Preoperative venous mapping was done in selected patients in whom physical examination was not contributory. All vascular accesses procedures were performed by a single vascular surgeon. We tried to utilise the various venous interconnections in the forearm and cubital fossa to create AVF, thereby Avoiding Arteriovenous Graft (AVG) which is 5-6 times costlier than AVF in our centre. Synthetic AV graft was done in the last resort only after exhausting all native veins for fistula creation.

Operative procedure

The venous drainage of upper limb has a lot of variations which was exploited in creation of AVF, thereby reducing the need for AVG creation. The venous interconnections which were used for AVF creation includes cephalic vein and accessory cephalic vein at the wrist; cephalic vein, and median vein of forearm at the mid forearm, cephalic vein, median cubital vein, medial cephalic and basilic vein at the elbow; cephalic vein, basilic vein in the arm (Figure 1).

The procedure was done under local anaesthetic (2% Xylocaine+0.25% Bupivacaine) injection. The anaesthetic agent was injected between the radial artery and cephalic vein during radio cephalic AVF creation and centering the brachial artery pulsation for Brachio-cephalic AVF creation. Regional anaesthesia was used for Brachio-basilic AVF with transposition. The arteriotomy size varies according to the inflow vessel (radial artery 6 - 8 mm, brachial artery 5 - 6mm). Both end to side anastamosis and side to side anastamosis with one end ligation was used in AVF creation. Side to side anastamosis with distal vein ligation was done during radio cephalic AVF creation. Side to side anastamosis with proximal ligation of basilic vein was done during creation of brachio cephalic AVF through median cubital or median basilic vein, whereas end to side anastamosis was done in brachio cephalic AVF. The modifications in AVF creation adapted in the present series includes at the wrist: ligation of oblique vein at the wrist, in the forearm: ligation of multiple tributaries to the main outflow vein in the forearm and in the elbow: ligation of the perforating vein, one of the main superficial veins (cephalic and basilic) and tributaries from forearm to cubital fossa. These tributaries were ligated through multiple stab incisions (Figure 2).

The idea behind the above described modifications in AVF creation is to augment the flow of blood to the outflow vein thereby enabling early maturation and to better patency rates. This will also prevent development of venous hypertension, steal phenomenon and high output cardiac failure. When the arterialised vein dilates, the tributaries with valves may become incompetent. Also if the functioning fistula develops stenosis or thrombosis, the segment of veins distal to the lesion may open up and lead to development of venous hypertension.

Isometric exercise was initiated after 6 hours of the procedure in all the patients. Patients were prescribed on low dose aspirin (75 mg) for one month. Patients were followed every 2 weeks after the procedure, till the cannulation of the access could work.

Primary failure was defined as fistula thrombosis, or failure to mature resulting in inadequate functioning for hemodialysis in 6 weeks.

Results

From September 2014 to December 2015, 107 AV access procedures were done in 102 patients. There were 78 (76.47%) males and 24 (23.53%) females. The mean age of patients was 51.41 years ranging from 17 to 87 years-old? The co-morbidities include diabetes mellitus in 43 (42.16%) patients, hypertension in 86 (84.31%), ischemic heart disease in 23 (22.55%) and malignancy in 2 (1.96%) patients. The etiology of chronic kidney disease included was unknown cause in 46 patients (45.10%), diabetic nephropathy in 35 (34.31%) patients, hypertensive nephropathy in 10 (9.80%) patients, chronic interstitial nephritis in 3 (2.94%) patients, chronic glomerulonephritis in 6 (5.88%) patients, and polycystic kidney disease in 2 (1.96%) patients. Only 6 patients (5.88%) underwent AV access creation in the predialysis stage whereas the rest 94.12% had their AV access created after the initiation of dialysis through temporary catheter. Five (4.67%) underwent second AVF creation due to prior fistula failure. The average follow-up period was 12 months ranging from 4 to 20 months?

AV access in our series include native AVF in 101 (94.39%) and AV graft in 6 (5.61%). AV access was created in right limb in 34 (31.77%) patients and left limb in 73(68.22%) patients. AVF was created at wrist in 34 (31.78%) patients, midforearm in 3 (2.80%), arm in 61 (57.01%) and saphenous vein translocation in 1(0.93%) patient.

Cephalic vein was used in 63 (58.88%) patients, median basilic or antecubital vein in 28 (26.17%) cases, basilic vein in 2 (1.87%) patients, median vein of forearm in 3 (2.80%) cases, saphenous vein in 3 (2.80%), accessory cephalic vein 2(1.87%) and AV graft in 6 (5.61%). Inflow arteries used for AVF creation included radial artery in 37 (34.58%) patients, brachial artery in 62 (57.94%) patients, and posterior tibial artery in 2 (1.87%) patients. Inflow artery used for AVG creation were ulnar artery in 1(0.93%) patient, brachial artery bifurcation in 1(0.93%) patient and brachial artery in 4(3.74%) patients. End (vein) to side (artery) anastamosis was done in 39 (36.45%) cases and side to side anastamosis was done in 68 (63.55%) cases. Thrill was present in 100 (93.46%) cases during the operation period.

Surgical complications included distal edema in 8 (7.48%) patients, seroma in 2 (1.87%) patients, hematoma in 2 (1.87%) patients, surgical site infection in 2 (1.87%) patients, and skin necrosis in 1 (0.93%) patient. Late complications include aneurysm formation in 4 patients (3.74%), distal steal phenomena in 1 (0.93%) patient, and AVG infection in 1 (0.93%) patient. Primary failure occurred in 9 (8.41%) patients due to thrombosis and maturation failure. Secondary failure occurred in 6 (5.61%) patients due to thrombosis and aneurysm. None of our patients had undergone any salvage procedure due to the high costs associated with such procedures in our centre.

Discussion

A functioning vascular access is the key to successful management of hemodialysis patients. Despite advances in the hemodialysis technology over years, vascular access continues to be a major determinant of morbidity and mortality for these patients. Native arteriovenous fistula is considered to be the ideal access of choice in most dialysis patients [1]. AVG has higher rates of access events, infections, greater mortality risk, and high costs of implantation compared to native fistula [2].

The most common etiology of chronic kidney disease in our series was unknown cause in 45.10% followed by diabetic nephropathy in 34.31% of patients. Due to poor predialysis care in our country, most of our patients were initiated on emergency hemodialysis through temporary catheter.

Citation: Elamaran E and Hemachandar R. Surgical Exploitation of Venous Interconnections in Upper Limb for Creation of Arteriovenous Vascular Access for Hemodialysis. Austin J Surg. 2016; 3(2): 1087. ISSN : 2381-9030